Scientists at Newcastle University have joined a new £50 million NIHR-funded national consortium aimed at tackling inequalities in cardiovascular disease.
Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), joins the global ...
The Rich family have seen first hand how much the drug can help children with a devastating Batten disease diagnosis ...
The Indian Institutes of Science Education and Research (IISERs) have invited applications for the IISER Aptitude Test (IAT) 2026, the exclusive gateway for admission to undergraduate programmes ...
Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results